Clinical Trial Update: Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) [Phase 2]

View source ↗

Summary

Phase 2 trial update for Coversin in Paroxysmal Nocturnal Haemoglobinuria (PNH) has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• Coversin (rVA576)

Snippet

Sponsor: AKARI Therapeutics | Conditions: Paroxysmal Nocturnal Haemoglobinuria (PNH) | Phase 2 | Status: COMPLETED | Results posted: 2023-07-12